The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

Pacira BioSciences PCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

New drug approved for treating chronic schizophrenia with fewer side effects. Could be beneficial for Black community.

A first-in-class pain med and blockbusters with new indications are just a few of the possible approvals to keep an eye on in ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

commented on the "significant number" of already-approved medications that were approved for new uses in 2024. One example is the weight-loss medication Wegovy, which was approved for ...

After thousands of complaints about complications, the FDA has issued an open letter to veterinarians to be alert to serious ...